A clever niche opportunity among mutual funds

(Full access for Members only)

A clever niche opportunity among mutual funds

29 November 2019

Mutual funds cannot legally keep hidden reserves. However, based on the current state of facts, this particular European equity fund is holding an investment that is virtually the equivalent of a hidden reserve. I call it "hidden potential".

Speaking figuratively, you can view this constellation either as buying a mutual fund with a discount, or as buying the indirect stake in this particular portfolio company for the prevailing price of October 2018 (that's not a typo).

The net result is the same. There is a very clever bargain to be had.

Sometime during 2020 and quite possibly as early as the next months, the fund could see a sudden increase in net asset value. This is likely going to be the case even if the rest of the fund's portfolio doesn't change in price at all.

I ran my findings past two colleagues to ask them if I should publish this as part of my free Weekly Dispatches. Their feedback was clear: "This is such a good opportunity that we need to limit this report to our website's paying Members! The information is literally worth money and should not go into the public domain."

Any EU resident can purchase this mutual fund, and it can probably also be bought by almost anyone who lives outside of the EU. Merely in the case of US-Americans there is a question mark if they can invest – probably yes, but I cannot guarantee it. The fund is available with a minimum investment of just EUR 100.

Without revealing anything else, I view this as an opportunity that is ideally suited for more conservative investors. It won't double in value overnight, but there is a nice gain to be made next year.

Not a Member yet? Sign up for a Membership - just USD 49/year.
Already a Member? Log into your account to download the report.

l  Report updates

Not a Member yet? Sign up for a Membership.
Already a Member? Log into your account to download the report updates.

27 May 2020

Report Update (PDF - 0.2MB)

3 April 2020

Report Update (PDF - 0.1MB)

Most recent

Latest reports (for Members only)

2-2.5x from an investment holding liquidation

2-2.5x from an investment holding liquidation

This AIM-listed small-cap will likely return all its capital to shareholders. Underresearched by investors, it's an opportunity that shouldn't even exist – but it does.

Ukraine reconstruction: one stock to benefit

Ukraine reconstruction: one stock to benefit

If or when the war in Ukraine ends, this stock will likely become the focus of investor money pushing into the country.

Actinium-225, aka "the world's rarest drug"

Actinium-225, aka "the world's rarest drug"

This little-known Western European company could become the global market leader for supplying the uber-rare "Ac-225", a potent weapon to treat cancer.